Product NDC: | 52959-030 |
Proprietary Name: | Cephalexin |
Non Proprietary Name: | Cephalexin |
Active Ingredient(s): | 250 mg/1 & nbsp; Cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52959-030 |
Labeler Name: | H.J. Harkins Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065229 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051201 |
Package NDC: | 52959-030-30 |
Package Description: | 30 CAPSULE in 1 BOTTLE (52959-030-30) |
NDC Code | 52959-030-30 |
Proprietary Name | Cephalexin |
Package Description | 30 CAPSULE in 1 BOTTLE (52959-030-30) |
Product NDC | 52959-030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cephalexin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20051201 |
Marketing Category Name | ANDA |
Labeler Name | H.J. Harkins Company, Inc. |
Substance Name | CEPHALEXIN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |